De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

Cancer shared this article with you from Inoreader De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma Via MedWorm Cancer & Oncology Clinical Trials Conditions:   HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage;   Oropharynx Cancer Interventions:   Procedure: Transoral robotic surgery;   Drug: Cisplatin - Dose Level 1;   Drug: Cisplatin - Dose Level 2;   Radiation: Dose Level 1;   Radiation: Dose Level 2 Sponsor:   Nebraska Methodist Health System Recruiting (Source: ClinicalTrials.gov) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.